Yuemei Liu

Title: **Inventor Yuemei Liu: Pioneering Drug Development for Phenylketonuria**

Introduction

Yuemei Liu, an innovative inventor based in Shenzhen, China, has made significant strides in the field of biotechnology. With one patent to her name, Liu is contributing to the development of healthcare solutions aimed at treating phenylketonuria (PKU), a metabolic disorder affecting amino acid metabolism.

Latest Patents

Liu's notable patent focuses on the "Use of NADH or salt thereof in preparation of drugs or health-care products for treating phenylketonuria." This patent outlines the application of nicotinamide adenine dinucleotide (NADH), or a salt of NADH, in formulations for treating PKU, specifying dosage recommendations of 1-100 mg per single dose.

Career Highlights

As a member of Hoboomlife Biotechnology Co., Ltd., Yuemei Liu has been dedicated to advancing medical biotechnology. Her work presents an alternative approach to managing PKU, enhancing the quality of life for those afflicted by the condition.

Collaborations

During her career, Liu has collaborated with accomplished professionals such as Rongzhao Fu and Qi Zhang. These collaborations have undoubtedly enriched her research, facilitating the development of effective healthcare products and drug formulations.

Conclusion

With her innovative approach, Yuemei Liu is making impactful contributions to the field of biotechnology. Her patent related to the treatment of phenylketonuria underscores her commitment to improving healthcare solutions, positioning her as an influential figure in the industry.